JACOB RUNYAN: Open Payments
NPI 1881022960 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 11 payments from 9 companies in 2025. Trend: 2023 $258 · 2024 $421 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 2 | $10 |
Products named: PAXLOVID, UBRELVY, Wegovy, REZDIFFRA, Veozah, SPRAVATO, XIFAXAN, AIRSUPRA.
Industry payments across NE — which companies pay providers there.
